Sun, Jingjing
Memorial Sloan Kettering Cancer Center · The University of Texas MD Anderson Cancer Center · Howard Hughes Medical Institute
3 papers on CoChatORCID 0000-0002-3087-8258
Most cited papers
- Verified
CTLA-4 blockade increases IFNγ-producing CD4 + ICOS hi cells to shift the ratio of effector to regulatory T cells in cancer patients
Liakou, C. I., Kamat, A., Tang, D. N., Chen, H., Sun, J., Troncoso, P., Logothetis, C., & Sharma, P. (2008) · Proceedings of the National Academy of Sciences
Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology
Cited by 549
- Verified
Preoperative CTLA-4 blockade: tolerability and immune monitoring in the setting of a presurgical clinical trial
Carthon, B. C., Wolchok, J. D., Yuan, J., Kamat, A., Ng Tang, D. S., Sun, J., Ku, G., Troncoso, P., Logothetis, C. J., Allison, J. P., et al. (2010) · Clinical Cancer Research
Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments
Cited by 460
- Verified
Anti-CTLA-4 therapy results in higher CD4 + ICOS hi T cell frequency and IFN-γ levels in both nonmalignant and malignant prostate tissues
Chen, H., Liakou, C. I., Kamat, A., Pettaway, C., Ward, J. F., Tang, D. N., Sun, J., Jungbluth, A. A., Troncoso, P., Logothetis, C., et al. (2009) · Proceedings of the National Academy of Sciences
Cancer Immunotherapy and BiomarkersProstate Cancer Treatment and Research
Cited by 218
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free